Heron Therapeutics, Inc. · NASDAQ:HRTX

Hensley Mark Earl exercised options for 31,250 Heron Therapeutics, Inc. shares (Form 4)

Traded Aug 6, 2026 · Filed Aug 10, 2026

On Aug 6, 2026, Hensley Mark Earl (Chief Operating Officer) exercised options for 31,250 Heron Therapeutics, Inc. shares, leaving 170,901 shares. Filed Aug 10, 2026 (Form 4).

Options exercised
31,250 shares
Holding after
170,901 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2026Common StockOption exercise31,250179,789Direct
Aug 6, 2026Common StockShares withheld for tax8,888US$0.50170,901Direct

Source

View original at SEC

Related